THORATEC HEARTMATE 3
Device
Abbott Laboratories
Total Payments
$497,375
Transactions
177
Doctors
2
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $497,375 | 177 | 2 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $497,375 | 177 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Antiplatelet Removal and HemocompatIbility EventS With the HeartMate 3 Pump IDE Study | Abbott Laboratories | $152,758 | 0 |
| Antiplatelet Removal and HemocompatIbility EventS in the HeartMate 3 Pump | Abbott Laboratories | $118,228 | 0 |
| valuation of the hemocompatibility of the Direct Oral AntiCoagulant apixaban in patients with HeartMate 3 Left Ventricular Assist Devices (DOAC-LVAD) | Abbott Laboratories | $48,713 | 0 |
| Impact of Hemodynamic Test and Continuous Pulmonary Artery Monitoring Guided HM 3 RPM and Medication Adjustments on Exercise Tolerance and Quality of Life | Abbott Laboratories | $36,000 | 1 |
| Human/Machine Interface: What the HeartMate3 Device Tells Us About the Future | Abbott Laboratories | $32,751 | 0 |
| Human/Machine Interface: What the HeartMate 3 Device Tells Us About the Future | Abbott Laboratories | $30,723 | 1 |
| Enhanced Nutritional Optimization in LVAD (ENOL) Trial | Abbott Laboratories | $20,975 | 0 |
| RAMP-IT-UP 3 | Abbott Laboratories | $18,000 | 0 |
| Assesment of Right Ventricular Electrophisiology as a Predictor of RV Performance after Left Ventriculat Assist Device Implanation | Abbott Laboratories | $15,500 | 0 |
| Implantation of the HeartMate 3 in Subjects With Heart Failure Using Surgical SWIFT HM3 PMS (SWIFT) | Abbott Laboratories | $11,989 | 0 |
| Human/?Machine Interface: What the HeartMate 3 Device Tells Us about the Future | Abbott Laboratories | $8,889 | 0 |
| RV Mapping Post-LVAD | Abbott Laboratories | $2,000 | 0 |
| TEAM-HF Study | Abbott Laboratories | $850.00 | 0 |
Ad
Manufacturing Companies
- Abbott Laboratories $497,375
Product Information
- Type Device
- Total Payments $497,375
- Total Doctors 2
- Transactions 177
About THORATEC HEARTMATE 3
THORATEC HEARTMATE 3 is a device associated with $497,375 in payments to 2 healthcare providers, recorded across 177 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2024 to 2024. In 2024, $497,375 was paid across 177 transactions to 2 doctors.
The most common payment nature for THORATEC HEARTMATE 3 is "Unspecified" ($497,375, 100.0% of total).
THORATEC HEARTMATE 3 is associated with 13 research studies, including "Antiplatelet Removal and HemocompatIbility EventS With the HeartMate 3 Pump IDE Study" ($152,758).